FDA advisers have recommended the approval of Guardant Health’s blood test to detect colon or rectal cancers — but it also raised some concerns, NBC News reported May 23.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA considers 2nd blood test for colon cancer — but advisers note concerns
